Steven Dayan, MD
Director, United States
Sabrina Fabi, MD
Physician, United States
Understanding the dynamic influences on the aesthetic patients’ needs and treatment goals, it is vital to evolve our patient-centric approach. From the impact of GLP-1 weight-loss to the growing desire of patients to achieve natural-looking facial balancing, key thought leaders Dr. Steven Dayan and Dr. Sabrina Fabi will share their insights and the most current clinical understandings to create treatment approaches that address long-term patient goals. George Baxter-Holder, DNP, MBA will demonstrate a holistic live-injection approach leveraging the newest FDA approvals for the Galderma portfolio. Audience Q&A.